Stay updated with breaking news from Timothyr Gershon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study by researchers at the UNC Lineberger Comprehensive Cancer Center demonstrates that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival of mice with medulloblastoma.
The novel combination of two nanoparticle-formulated drugs has shown to extend the survival of mice with medulloblastoma
CHAPEL HILL, NC—UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that a novel combination of two drugs that act as targeted
UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival of mice with medulloblastoma.
Researchers from the Lineberger Comprehensive Cancer Center of the University of North Carolina (UNC) have shown that a unique combination of two drugs that serve as targeted inhibitors, supplied in a nanoparticle formulation, prolong the survival of mice with medulloblastoma.